Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 146

Taking the good times with The Bard

In the midst of heightened anxiety over the possibility of another financial crisis and market turmoil, 2016 marks the 400th anniversary of Shakespeare’s death. While most people don't pick up Shakespeare's plays when they're looking for investment advice, Shakespeare did write frequently about money matters.

“How poor are they that have not patience! What wound did ever heal but by degrees?" – Iago in Othello in Act 2, Scene 3. Or in plain English: patience pays off.

“Neither a borrower nor a lender be; For loan oft loses both itself and friend, And borrowing dulls the edge of husbandry." – Polonius in Hamlet Act I, Scene 3. In other words, don't spend money you don't have.

“Foul-cankering rust the hidden treasure frets, But gold that's put to use more gold begets." – Venus and Adonis, a poem. Or more simply: Don't put your money under the mattress.

Where the Bard and markets meet

Shakespeare’s plays often turn on the idea of fate. Controlling one’s fate seemed to have become part of the human consciousness by Shakespeare’s time but not yet the competencies to achieve that end. Instead, those who tested fate usually ended up dead. These themes are explored most vividly in The Tragedy of Julius Caesar. Caesar receives all sorts of apparent warning signs, which he ignores, proudly insisting that they point to someone else’s death. Then Caesar is assassinated.

Given the rough start to the year, you may wonder if we made the same mistake as Caesar by ignoring the warning signs. After all, our expectation for a better 2016 (compared to 2015) did not get off to a good start.

What was the trigger for such a panic in January? China, oil and Fed worries were nothing new. The same worries led us to take out portfolio hedges and reduce growth exposure from the second half of 2015 when market complacency was high. While these tail hedging strategies paid off, they were not enough to offset the negative contribution from the exposures to commodities and Asian shares.

As 2015 drew to a close, many of our sentiment and valuation indicators had made a significant positive adjustment (mostly during the August-October correction), macro indicators were showing signs of steady improvement and financial conditions in China were looking up. Then a few people got back to work in early January and listened to interviews by some hedge fund gurus on how China is about to implode and that central banks are out of ammunition. Panic buttons were hit despite the fact these gurus have been making the same predictions ever since the GFC. With markets down sharply, the next group of sellers showed up and decided to sell based on the idea that 'maybe the market is telling us something’.

Reasons not to join the panic

For now, major equity indices have found support at key support areas, as markets now focuses on:

  • Little or no signs of credit crunch even as global banks came under fire.
  • Easing financial conditions in China, and after a year of monetary easing, real yields are falling and loan growth is picking up steam.
  • Significant improvement in valuation measures. Of course, valuations are not great timing indicators and just because valuations are cheap doesn’t mean markets can’t fall further. However, when valuation signals move to historical extremes, it pays to take notice.

History shows time and time again that strong positive returns can be achieved by investing in the share market when the economic news is negative, and bad news is well covered and reflected in valuation measures. However, investors as a group fail to exploit valuation anomalies. Why? Because there is a price to pay and that’s accepting short-term volatility.

While downside selling pressure has shown signs of easing, evidence of buying pressure will need to emerge. Improved earnings prospects against much pessimistic expectations and further policy support from Europe, China, Japan and US (through delayed further rate hikes) should lead to reduced short-term volatility and a re-rating of equities. The most significant risk to market stability, however, continues to be the US dollar.

What if China implodes?

For Chinese H shares, valuations (extremely cheap), cycle (leading indicators of growth are turning up), monetary policy (significant improvement in monetary conditions), technicals (waning downside participation across individual stocks) and sentiment indicators (extreme pessimism) are all green. Rarely do we find an asset class that gets a tick across so many drivers.

Of course, none of this matters if the predictions of some US hedge fund gurus are right and Chinese banks collapse. Their calls on financial Armageddon in China have gained widespread coverage (so much that we received several emails from some worried clients).

In our view, as with all things in China, the spectre of a financial crisis is an intensely political concern. Should a financial crisis occur in China, it will be because all options to prevent such a profound dislocation have been tried and failed. Indeed, China is one of the very few countries in the world with the ability to boost fiscal support, and that’s what we have seen in recent months.

In summary, despite the intense market weakness since the start of the year, increasing calls of an imminent global recession and financial meltdown, our focus was and is to remain objective. We continue to expect market turbulence to settle down soon. Further breakdown in emerging market currencies, another bout of underperformance by cyclically-sensitive sectors and falling inflation expectations (pushing real yields higher) will be examples of such dynamics that will warrant a shift in allocation towards a more defensive stance.

 

Nader Naeimi is Head of Dynamic Markets at AMP Capital. This article is a general view and does not address the specific circumstances of any investor.

 


 

Leave a Comment:

RELATED ARTICLES

Cyclical stocks will drive markets higher in 2025

Hold fire on your fund manager over short-term declines

5 charts that should give investors hope amidst market turmoil

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Avoiding wealth transfer pitfalls

Australia is in the early throes of an intergenerational wealth transfer worth an estimated $3.5 trillion. Here's a case study highlighting some of the challenges with transferring wealth between generations.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.